Status:
COMPLETED
Stanford PIPRA Validation Study in an Elderly Orthopedic Population
Lead Sponsor:
Stanford University
Conditions:
Delirium
Postoperative Delirium
Eligibility:
All Genders
65+ years
Brief Summary
The purpose of this study is to determine the accuracy of an AI-based tool in the prediction of postoperative delirium (POD), in a population at moderately high risk of developing this syndrome (i.e.,...
Detailed Description
Study investigators would like to determine the real-life accuracy of a new tool developed for the prediction of delirium: Pre-Interventional Preventive Risk Assessment (PIPRA) Tool. The importance of...
Eligibility Criteria
Inclusion
- Surgical patients
- Greater than or equal to 65 years old
- ASA I, II or III
- Greater than 90 min of surgery
- Non-cardiac surgery
Exclusion
- Dementia
- Alzheimer's
- Parkinson's
- Current Benzodiazepine use
- Alcoholism
- Previous surgery within the last 12 months or expected in the 12 months to come (except the expected surgery for which they are being enrolled).
- Color-blindness
Key Trial Info
Start Date :
April 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06567574
Start Date
April 30 2024
End Date
June 30 2024
Last Update
August 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Medical Center
Palo Alto, California, United States, 94304